Harm-reduction cigarettes are more toxic than traditional cigarettes, UC Riverside study finds

December 08, 2008

RIVERSIDE, Calif. - Typically, tobacco companies market harm-reduction cigarettes as being safer than traditional "full-flavored" brands, leading many smokers to conclude that the use of harm-reduction brands lowers their exposure to toxicants.

But a UC Riverside study now shows that smoke from these "light" or "low-yield" harm-reduction cigarettes retains toxicity and that this toxicity can affect prenatal development.

"Many chemicals found in harm-reduction cigarette smoke have not been tested, and some are listed by manufacturers as safe," said Prue Talbot, a professor of cell biology who led the study. "But our tests on mice clearly show that these chemicals adversely affect reproduction and associated development processes. The effects are likely to be the same in humans, in which case pregnant women would be particularly vulnerable to the effect of smoke from these cigarettes."

Talbot's research team used mouse embryonic stem cells (mESCs) as a model for pre-implantation embryos--embryos that have not yet implanted in the wall of the uterus--and compared the toxicity on these cells of cigarette smoke emanating from traditional and harm-reduction brands.

Further, they studied the effects on the mESCs of two kinds of cigarette smoke: mainstream smoke, which is smoke actively inhaled by smokers; and sidestream smoke, which is smoke that burns off the end of a cigarette.

They found that both kinds of smoke from traditional and harm-reduction cigarettes are toxic to pre-implantation embryos and can retard growth or kill embryonic cells at this stage of development. Equally surprising to them was their discovery that mainstream smoke and sidestream smoke from harm-reduction cigarettes are more potent than the corresponding smoke from traditional brands of cigarettes.

"This result was unexpected since harm reduction brands purportedly have lower concentrations of toxicants," Talbot said.

"Dr. Talbot's work significantly enhances our understanding of the harmful effects of smoking on very early pregnancy," said Olga Genbacev, a senior scientist in the Department of Obstetrics, Gynecology and Reproductive Sciences at UC San Francisco, who was not involved in the research. "This study for the first time sends a clear message to nonsmoking women of reproductive age who are planning to become pregnant that they must avoid exposure to sidestream smoke."

Study results appear in the journal Human Reproduction (published online, Nov. 29). The hardcopy version of the research paper is scheduled to appear in January 2009.

"Clearly, the tobacco companies have not eliminated all toxins from harm-reduction brands of cigarettes," said Talbot, who also is the director of the UCR Stem Cell Center. "We found that both mainstream and sidestream smoke from traditional and harm-reduction cigarettes hindered the attachment of mESCs to extracellular materials. Such attachment is crucial to normal embryonic development. Moreover, cell survival and proliferation--also necessary for embryonic growth--were hindered as well."

The researchers' experiments on the mESCs showed, too, that on a per puff basis sidestream smoke was more potent than mainstream smoke in both traditional and harm-reduction brands of cigarettes.

"This may be because sidestream smoke is produced at a lower temperature and therefore contains higher concentrations of toxicants," Talbot said.

When she and her colleagues performed the experiments directly on pre-implantation mouse embryos that had been cultured for one hour in mainstream or sidestream smoke solutions from a harm-reduction brand, they found that the effect of smoke on the embryos was similar to the effect it had on the mESCs.

"This strongly supports our use of embryonic stem cells as a valuable and effective model to study embryo toxicity during pre-implantation development," said Sabrina Lin, a graduate student in the Cell, Molecular and Developmental Biology Program working towards her doctoral degree, and the first author of the research paper. "This means we can use human embryonic stem cells to draw conclusions about the effect of cigarette smoke on pre-implantation human embryos."

Next in their research, Talbot and Lin plan to conduct their experiments on human embryonic stem cells.

"To relate this research more strongly to humans, we have to use human embryonic stem cells," Talbot said. "Sabrina has already started working on them, and her preliminary results are similar to those with mESC."
-end-
Talbot and Lin were joined in the 18-month study by Vu Tran, who graduated from UCR in 2007 and is now at the Ross University School of Medicine, West Indies.

The Tobacco-Related Disease Research Program of the University of California provided funding for the study.

The UCR Stem Cell Center, which oversees research, teaching, and outreach activities related to stem cells, will work with faculty in UCR's School of Medicine, and broaden the university's participation in translational applications of stem cell biology.

The UCR School of Medicine is projected to enroll its first incoming class of students in fall 2012.

The University of California, Riverside is a doctoral research university, a living laboratory for groundbreaking exploration of issues critical to Inland Southern California, the state and communities around the world. Reflecting California's diverse culture, UCR's enrollment of about 17,000 is expected to grow to 21,000 students by 2020. The campus is planning a medical school and has reached the heart of the Coachella Valley by way of the UCR Palm Desert Graduate Center. The campus has an annual statewide economic impact of more than $1 billion. To learn more, visit www.ucr.edu or call (951) UCR-NEWS.

University of California - Riverside

Related Embryonic Stem Cells Articles from Brightsurf:

New mechanisms that regulate pluripotency in embryonic stem cells are discovered
A study by researchers at the Center for Cell-Based Therapy, which is supported by FAPESP, identified microRNAs involved in pluripotency maintenance and cell differentiation.

Embryonic mammary gland stem cells identified
Research team led by Prof. C├ędric Blanpain identified the mechanisms that regulate mammary gland development.

New insights into mechanisms regulating gene expression in embryonic stem cells
Researchers from Turku, Finland, have discovered new information about the mechanisms which maintain gene activity in human embryonic stem cells.

New tools to study the origin of embryonic stem cells
Researchers at Karolinska Institutet have identified cell surface markers specific for the very earliest stem cells in the human embryo.

Scientists approve the similarity between reprogrammed and embryonic stem cells
Researchers from the Vavilov Institute of General Genetics, Research Institute of Physical Chemical Medicine and Moscow Institute of Physics and Technology (MIPT) have concluded that reprogramming does not create differences between reprogrammed and embryonic stem cells.

Drug makes stem cells become 'embryonic' again
If you want to harness the full power of stem cells, all you might need is an eraser -- in the form of a drug that can erase the tiny labels that tell cells where to start reading their DNA.

Oncogene controls stem cells in early embryonic development
Many animal species delay the development of their embryos to ensure that their offspring is born at a favorable time.

Are embryonic stem cells and artificial stem cells equivalent?
Harvard Stem Cell Institute (HSCI) researchers at Massachusetts General Hospital and Harvard Medical School have found new evidence suggesting some human induced pluripotent stem cells are the 'functional equivalent' of human embryonic stem cells, a finding that may begin to settle a long running argument.

UCSF researchers control embryonic stem cells with light
UCSF researchers have for the first time developed a method to precisely control embryonic stem cell differentiation with beams of light, enabling them to be transformed into neurons in response to a precise external cue.

Protein plays unexpected role in embryonic stem cells
A protein long believed to only guard the nucleus also regulates gene expression and stem cell development.

Read More: Embryonic Stem Cells News and Embryonic Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.